Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
CRISPR Therapeutics Price
CRISPR Therapeutics price

CRISPR Therapeutics tokenized stock pricerCRSP

Bitget rToken: 1:1 pegged to real U.S. stocks
Listed
Buy rCRSP
$53.4USD
-0.67%1D
The price of CRISPR Therapeutics (rCRSP) in United States Dollar is $53.4 USD.
CRISPR Therapeutics/USD live price chart (rCRSP/USD)
Last updated as of 2026-08-17 01:41:37(UTC+0)
All rToken price data comes from Bitget's spot stock trading market as well as Nasdaq or the NYSE.

In-depth analysis of CRISPR Therapeutics's market trends today

CRISPR Therapeutics market summary

The current price of CRISPR Therapeutics (rCRSP) is $53.4, with a 24-hour change of -0.67%. The current market capitalization is approximately --, and the 24-hour trading volume is $0.00.

CRISPR Therapeutics Key Takeaways

Based on real-time chart analysis, the current technical structure for CRISPR Therapeutics (rCRSP) shows a key support level at $52.00 and a primary resistance level at $55.00. A decisive move outside of this range could trigger a new trending phase for the stock. Overall, the market is currently in a sideways consolidation with a bullish bias phase, as the price stabilizes after recent gains while testing upper resistance zones.

Technical Indicators

RSI: The current RSI is approximately 59.45, indicating that market momentum is neutral to slightly bullish, moving away from previous oversold conditions but not yet in extreme overbought territory.
MACD: The signal is bullish, with the MACD line recently turning positive and a bullish crossover occurring in early August, suggesting increasing upward pressure.
MA: The MA structure is positive; the price is currently trading above the 50-day moving average ($52.24) and the 20-day moving average ($49.52), showing a strong short-to-medium term bullish trend.

Market Drivers

Current CRISPR Therapeutics price action and market sentiment are primarily driven by the following factors:
CASGEVY Revenue Growth: Strong financial results for Q2 2026, with CASGEVY generating $76 million in revenue, representing 151% year-over-year growth, bolstered by recent FDA approval for children as young as 2 years old.
Clinical Pipeline Expansion: Positive sentiment following the initiation of Phase 1 trials for CTX340 (hypertension) and CTX460 (AATD), alongside upcoming durability data for CTX310 at the ESC Congress 2026.
Regulatory Momentum: Completed regulatory submissions in the Kingdom of Saudi Arabia and the United Kingdom for pediatric indications, expanding the addressable market for the company’s lead gene therapy.

Trading Signals

Based on current technical structures and market momentum, the following trading strategies are provided for reference:

Potential Buy Zone

• If the CRISPR Therapeutics price approaches the $52.00 - $52.80 support zone and shows signs of a bounce, it may present a short-term buying opportunity.
• If the price breaks above the $55.00 resistance level with a significant increase in trading volume, it would likely confirm a continuation of the upward trend.

Risk Scenario

• If the price falls and closes below the $52.00 support level, the market may enter a short-term correction phase, potentially retesting the $49.50 area.

Buy Strategy

Based on the current market structure, the following strategies are suggested:

Conservative Investors

• Wait for a price pullback to the $52.00 support level to build positions in stages.
• Alternatively, wait for a confirmed breakout and hold above the $55.00 resistance before entering.

Trend Investors

• If the price breaks the $55.00 resistance, a new bullish leg could form. The next target price is estimated at $58.10.

Long-term Investors

• As long as the price remains above the $52.00 key structural support, the medium-to-long term outlook remains constructive, supported by strong revenue growth and pipeline milestones.

Trends Summary

Market Insights

From a short-term perspective, CRISPR Therapeutics has displayed a steadily rising price structure over the past 7 days, with market sentiment turning optimistic following the Q2 earnings report. Medium-term analysis shows the price fluctuating within the $52.00 to $55.00 range as it attempts to break out of a longer-term horizontal channel.

Market Outlook

• If the price successfully breaks $55.00, the next target level is $58.10, followed by $61.20.
• If the price fails to hold $52.00, the next downside target is $49.50.

Market Consensus

The consensus among analysts is that while CRISPR Therapeutics may experience short-term consolidation near resistance, the medium-term trend remains bullish as long as the price stays above the $52.00 support level, driven by the commercial success of CASGEVY and clinical trial progress.

Now that you understand the market, it's time to start trading. CRISPR Therapeutics (rCRSP) is actively traded on Bitget Exchange, one of the world's largest cryptocurrency platforms with over 120 million registered users. Bitget offers spot trading for rCRSP/USDT with highly competitive fees, as low as 0% for makers and 0.03% for takers. The platform supports more than 1300 cryptocurrencies including CRISPR Therapeutics, maintains a protection fund exceeding $300 million, and provides 24/7 trading with deep liquidity. Bitget consistently ranks among the top exchanges by rCRSP trading volume.

Sign up for a free Bitget account and start trading now!

Risk disclaimer

The above analysis is based on Bitget's real-time chart data and technical indicators, compiled and reviewed by the Bitget research team. It is for reference only and does not constitute investment advice. Cryptocurrency prices are highly volatile. Please make investment decisions based on your own risk tolerance.

Show more5m ago
GetAgent

GetAgent: Your AI for smarter trading decisions

What news is moving rCRSP right now?
What could affect rCRSP's future price?
What should I watch for rCRSP this week?
Is market sentiment bullish or bearish for rCRSP right now?
What key levels are traders watching for rCRSP?
What upcoming events could move rCRSP's price?
Is there strong buying or selling pressure on rCRSP right now?
The Trump administration has listed stabilizing oil prices as its top priority. Will crude oil assets decline?
Zijin Gold’s gold production from mineral resources in the first half of the year rose 44%. Is this the time to get in?
S&P 500 earnings growth hits a 30-year high and the P/E ratio falls to 22x— is this the right time to get in?
Ask anything on GetAgent
Buy/sell now

CRISPR Therapeutics market info

Price performance (24h)
24h
24h low $53.424h high $53.76
All-time high (ATH):
$221
Price change (24h):
-0.67%
Price change (7D):
-0.67%
Price change (1Y):
+2.91%
Diluted EPS
-4.76 USD
Dividend yield
0.00%
Net profit (fiscal year)
−581.60M USD
Revenue (fiscal year)
3.51M USD
Next earnings date
Aug 10, 2026
Next quarter revenue forecast
7.45M USD
Beta (1-year)
1.99
Contracts:
--
Links:
Buy/sell CRISPR Therapeutics now

Live CRISPR Therapeutics price today in USD

The live CRISPR Therapeutics price today is $53.4 USD, with a current market cap of --. The CRISPR Therapeutics price is down by 0.67% in the last 24 hours, and the 24-hour trading volume is $0.00. The rCRSP/USD (CRISPR Therapeutics to USD) conversion rate is updated in real time.
How much is 1 CRISPR Therapeutics worth in United States Dollar?
As of now, the CRISPR Therapeutics (rCRSP) price in United States Dollar is valued at $53.4 USD. You can buy 1rCRSP for $53.4 now, you can buy 0.1873 rCRSP for $10 now. In the last 24 hours, the highest rCRSP to USD price is $53.76 USD, and the lowest rCRSP to USD price is $53.4 USD.

Do you think the price of CRISPR Therapeutics will rise or fall today?

Total votes:
Rise
0
Fall
0
Voting data updates every 24 hours. It reflects community predictions on CRISPR Therapeutics's price trend and should not be considered investment advice.
The following information is included:CRISPR Therapeutics price prediction, CRISPR Therapeutics project introduction, development history, and more. Keep reading to gain a deeper understanding of CRISPR Therapeutics.

CRISPR Therapeutics price prediction

What will the price of rCRSP be in 2027?

In 2027, based on a +5% annual growth rate forecast, the price of CRISPR Therapeutics(rCRSP) is expected to reach $57.58; based on the predicted price for this year, the cumulative return on investment of investing and holding CRISPR Therapeutics until the end of 2027 will reach +5%. For more details, check out the CRISPR Therapeutics price predictions for 2026, 2027, 2030-2050.

What will the price of rCRSP be in 2030?

In 2030, based on a +5% annual growth rate forecast, the price of CRISPR Therapeutics(rCRSP) is expected to reach $66.65; based on the predicted price for this year, the cumulative return on investment of investing and holding CRISPR Therapeutics until the end of 2030 will reach 21.55%. For more details, check out the CRISPR Therapeutics price predictions for 2026, 2027, 2030-2050.

You can trade rCRSP on Bitget

  • #
  • Pair
  • Type
  • Price
  • 24h volume
  • Action
  • 1
  • rCRSP/USDT
  • Spot
  • 53.4
  • $5.7K
  • Trade
  • Hot stock assets trading on Bitget

    Spot stocks
    Stock perps
  • #
  • Pair
  • Type
  • Price
  • 24h volume
  • Action
  • 1
  • rEA/USDT
  • Spot
  • 209.91
  • $11.23B
  • Trade
  • 2
  • rHYG/USDT
  • Spot
  • 79.68
  • $1.24B
  • Trade
  • 3
  • rSYK/USDT
  • Spot
  • 339.14
  • $644.73M
  • Trade
  • 4
  • rALL/USDT
  • Spot
  • 263.71
  • $591.24M
  • Trade
  • 5
  • rFIX/USDT
  • Spot
  • 1773.5
  • $579.37M
  • Trade
  • 6
  • rAGG/USDT
  • Spot
  • 97.56
  • $544.68M
  • Trade
  • 7
  • rSNXX/USDT
  • Spot
  • 16.46
  • $532.98M
  • Trade
  • 8
  • rAZO/USDT
  • Spot
  • 3036.5
  • $526.38M
  • Trade
  • 9
  • rVRTX/USDT
  • Spot
  • 508.08
  • $491.8M
  • Trade
  • 10
  • rEEM/USDT
  • Spot
  • 66.66
  • $473.9M
  • Trade
  • Detailed introduction to Bitget rToken (rCRSP)

    Key features of Bitget rToken (rCRSP)
    Asset attributeA tokenized stock pegged 1:1 to a real U.S. stock.
    IssuerReality (Bitget's licensed RWA protocol).
    DividendsDividends are automatically distributed to your account in USDT, with no manual action required.
    Fractional shareSupports fractional share trading, starting from as low as 1 USDT.
    Trading hoursSome rTokens offer native U.S. stock liquidity 24/5, while others support 24/7 trading.
    How to buyCan be purchased directly with USDT, USDC, or BTC, with no conversion required.
    Position usageCan be held as an investment position, and also used as combined margin for Bitget's unified trading account and USDT-M futures.

    In short, rCRSP is a tokenized stock issued by licensed issuer Reality, pegged 1:1 to real CRISPR Therapeutics stock. It supports 24/7 trading, fractional shares, and dividends, and can be used as margin for the platform's unified trading account and USDT-M futures.

    Buy rCRSP

    How Bitget rToken (rCRSP) works

    During U.S. market hours—including the regular session, pre-market, after-hours, and overnight sessions—spot orders for rCRSP are routed directly through a broker to the Nasdaq or NYSE order book. Once the trade is executed on the U.S. stock market, the execution result is reflected in the on-exchange spot order record. Any order you place for rCRSP while the U.S. market is open will also appear on the Nasdaq or NYSE order book. This means that during U.S. market hours, the trading price and liquidity of rCRSP are exactly the same as those of the underlying stock. Orders for rCRSP and their execution results are part of the U.S. stock market. There is no spread or so-called de-pegging, because rCRSP trades are executed directly on the U.S. stock market itself. The execution price you see for rCRSP is identical to the stock's price at that exact moment.

    This makes rCRSP fundamentally different from traditional RWA tokens. The price of a traditional RWA asset is determined by on-chain liquidity and trading activity, whereas the price of rCRSP is directly equivalent to the stock price—it does not rely on any other mechanism to peg the asset's price. In terms of trading outcomes, trading rCRSP is no different from trading the stock directly.

    Buy rCRSP with crypto assets on Bitget for the best stock trading experience

    Bitget's spot trading market has listed over 500 rTokens (including rCRSP), offering native U.S. stock liquidity 24/5, with some trading pairs supporting 24/7 trading.

    Market liquidity: The only tokenized stock that aligns with the market price and liquidity of major U.S. stock exchanges such as Nasdaq and the NYSE.

    Maximum capital efficiency: rTokens can be used within the unified ecosystem for margin, Crypto Loans, Earn, and more, expanding the ways your assets can be used.

    More flexible trading: Supports stablecoin deposits, T+0 fund turnover, 24/5 trading, with some pairs supporting 24/7 trading.

    Fund security: The only RWA asset in the industry subject to daily third-party Proof of Reserves (PoR) audits, ensuring transparent asset reserves and protecting user funds.

    Dividend rights: Eligible dividends are paid out to users' accounts in USDT.

    Hold rCRSP and enjoy corporate actions aligned with the underlying stock

    Corporate actions involving rCRSP (including dividend payments, stock splits, and reverse splits) are handled in the same way that a traditional broker would handle a stock position.

    While holding rCRSP, whenever CRISPR Therapeutics stock pays a USD dividend, Reality automatically converts it into an equivalent amount of stablecoin (USDT) and distributes it 1:1 to the Bitget accounts of rCRSP holders. As a result, holding rCRSP entitles you to the same dividend rights as holding the actual stock, with the entire process handled automatically by the platform, requiring no manual action. It should be noted that dividends are subject to a flat 30% withholding tax applied by the U.S. to foreign investors. For users holding high-dividend assets (such as certain tech stocks or ETF-linked tokens), this means they can earn steady passive income on top of capital appreciation, further boosting the overall return on their holdings.

    The issuer of rCRSP is based in El Salvador. Therefore, the withholding tax applicable to rCRSP follows the U.S. withholding tax rules for El Salvador.

    Hold rCRSP and enjoy the flexibility of a crypto asset

    Whether you're using a traditional broker or another platform, deposits and withdrawals are rarely a seamless experience. Traditional brokers may take time to process deposits. After a stock is sold, withdrawals typically take one to two days to process, and the funds may take even longer to arrive. Securities holdings also cannot be split, transferred, or reallocated. By contrast, rCRSP offers far greater flexibility than traditional stocks.

    1. rCRSP can be sold on the exchange, and the proceeds are immediately available for transfer, with no T+1 restriction.

    2. rCRSP can be freely transferred, withdrawn, or moved between sub-accounts, offering great flexibility and convenience. rCRSP is essentially a regular crypto asset, with no difference in use from Bitcoin.

    3. rCRSP can be used directly as margin in a unified trading account to open futures positions. This allows users to participate in derivatives trading without selling their stock holdings, improving capital efficiency.

    4. rCRSP can be used as collateral to borrow crypto assets such as USDT, USDC, and BTC on the platform for further trading or to purchase other rToken assets. This is similar to the margin lending services offered by traditional brokers and helps improve capital efficiency.

    Understanding the risks

    The advantage of rCRSP is that its price is exactly the same as the underlying stock's while also benefiting from the stock's deep liquidity. Even for less actively traded stocks, institutions don't need to worry about unexpected liquidations caused by price spikes resulting from insufficient on-exchange liquidity, as can happen with traditional tokens.

    During weekends, when the U.S. stock market is closed, rCRSP continues to function as collateral without interruption. Even though rCRSP remains tradable over the weekend, its collateral value continues to be based on the last price before the U.S. market closes on Friday. This fixed index price is used for risk calculations, helping maintain a relatively stable collateral value and liquidation risk profile.

    Why choose Bitget rToken? What are the main advantages of Bitget rToken over traditional stock investing?

    AspectBitget rTokenTraditional brokers
    Simple account openingSign up with a mobile number or email address and complete identity verification—no proof of address requiredComplex account opening process (utility bills, etc.), requiring proof of address
    1:1 asset backingEach rToken corresponds to a real stock held in custody by a brokerDirect stock ownership
    Liquidity experienceSupports fractional-share trading from as little as 1 USDT, with 24/7 millisecond-level execution and seamless execution for large ordersSome brokers support fractional-share investing, but execution is limited by clearing firms, resulting in insufficient liquidity
    Transaction feesMaker fees as low as 0%; taker fees as low as 0.03%; no broker commissionsComplex fee structure: commissions ($0–$5 per trade), platform fees, exit fees, etc.
    Funding and currenciesBuy directly with USDT or BTC—no currency conversion requiredRequires fiat deposits, with exchange-rate losses on currency conversion
    Trading hours24/7 trading—buy or sell anytime, unrestricted by U.S. stock market hoursMostly limited to 9:30 AM–4:00 PM (EST) on trading days, with only some brokers supporting 24/5 trading
    Deposits and withdrawals24/7 near-instant deposits and withdrawals, with support for USDT, USDC, and other cryptocurrencies, plus direct wallet accessTraditional bank deposits, limited currency support, 1–2 working days, plus fees and exchange-rate losses
    Dividend distributionDividends are automatically paid to your wallet—no manual action requiredRequires manual reinvestment or waiting for a dividend check
    Regulatory complianceIssued by Reality Protocol (a licensed RWA issuer)SEC-registered brokers
    Asset security100% asset backing, plus a $300 million user protection fundInconsistent clearing rules; SIPC coverage capped at $500,000
    Buy rCRSP now

    Where is the best place to buy crypto like CRISPR Therapeutics (rCRSP)?

    Trading statisticsBitget
    Spot trading fee (maker)As low as 0%
    Spot trading fee (taker)As low as 0.03% (0.024% with BGB)
    Futures trading fee (maker)As low as 0%
    Futures trading fee (taker)As low as 0.02%
    Max leverage (futures)125x
    Fiat trading fee0%
    Supported crypto assets1,300+
    Copy trading assets600+
    Protection fund value$300M+
    100% Proof of ReservesReserve ratio > 100% (verified by Merkle tree)
    Global users120M+
    Daily trading volume$20B+

    rCRSP/USD price calculator

    rCRSP
    USD
    1 rCRSP = 53.4 USD. The current price of converting 1 CRISPR Therapeutics (rCRSP) to USD is 53.4. This rate is for reference only.
    Bitget offers the lowest transaction fees among all major trading platforms. The higher your VIP level, the more favorable the rates.

    rCRSP resources

    CRISPR Therapeutics rating
    4.5
    0 ratings
    Contracts:
    --
    Links:

    What can you do with cryptos like CRISPR Therapeutics (rCRSP)?

    Deposit easily and withdraw quicklyBuy to grow, sell to profitTrade spot for arbitrageTrade futures for high risk and high returnEarn passive income with stable interest ratesTransfer assets with your Web3 wallet

    How do I buy CRISPR Therapeutics?

    Learn how to get your first CRISPR Therapeutics in minutes.

    1. Create a free Bitget account.

    2. Select a funding method.

    3. Buy your target crypto.

    Buy now!See the tutorial

    How do I sell CRISPR Therapeutics?

    Learn how to cash out your CRISPR Therapeutics in minutes.

    1. Create a free Bitget account.

    2. Deposit crypto into your Bitget account.

    3. Exchange your assets for fiat on the P2P market or for USDT on the spot market.

    Sell now!See the tutorial

    What is CRISPR Therapeutics and how does CRISPR Therapeutics work?

    CRISPR Therapeutics is a popular cryptocurrency. As a peer-to-peer decentralized currency, anyone can store, send, and receive CRISPR Therapeutics without the need for centralized authority like banks, financial institutions, or other intermediaries.
    See more

    FAQ

    What is the current price of CRISPR Therapeutics?

    The live price of CRISPR Therapeutics is $53.4 per (rCRSP/USD) with a current market cap of $0 USD. CRISPR Therapeutics's value undergoes frequent fluctuations due to the continuous 24/7 activity in the crypto market. CRISPR Therapeutics's current price in real-time and its historical data is available on Bitget.

    What is the 24 hour trading volume of CRISPR Therapeutics?

    Over the last 24 hours, the trading volume of CRISPR Therapeutics is --.

    What is the all-time high of CRISPR Therapeutics?

    The all-time high of CRISPR Therapeutics is $221. This all-time high is highest price for CRISPR Therapeutics since it was launched.

    Can I buy CRISPR Therapeutics on Bitget?

    Yes, CRISPR Therapeutics is currently available on Bitget’s centralized exchange. For more detailed instructions, check out our helpful How to buy crispr-therapeutics-tokenized-stock-reality guide.

    Can I get a steady income from investing in CRISPR Therapeutics?

    Of course, Bitget provides a strategic trading platform, with intelligent trading bots to automate your trades and earn profits.

    Where can I buy CRISPR Therapeutics with the lowest fee?

    Bitget offers industry-leading trading fees and depth to ensure profitable investments for traders. You can trade on the Bitget exchange.

    Prices of newly listed coins on Bitget

    Hot promotions

    Where can I buy CRISPR Therapeutics (rCRSP)?

    Buy crypto on the Bitget app
    Sign up within minutes to purchase crypto via credit card or bank transfer.
    Download Bitget APP on Google PlayDownload Bitget APP on AppStore
    Trade on Bitget
    Deposit your cryptocurrencies to Bitget and enjoy high liquidity and low trading fees.

    Video section — quick verification, quick trading

    play cover
    How to complete identity verification on Bitget and protect yourself from fraud
    1. Log in to your Bitget account.
    2. If you're new to Bitget, watch our tutorial on how to create an account.
    3. Hover over your profile icon, click on “Unverified”, and hit “Verify”.
    4. Choose your issuing country or region and ID type, and follow the instructions.
    5. Select “Mobile Verification” or “PC” based on your preference.
    6. Enter your details, submit a copy of your ID, and take a selfie.
    7. Submit your application, and voila, you've completed identity verification!
    Buy CRISPR Therapeutics for 1 USD
    A welcome pack worth 6200 USDT for new Bitget users!
    Buy CRISPR Therapeutics now
    Cryptocurrency investments, including buying CRISPR Therapeutics online via Bitget, are subject to market risk. Bitget provides easy and convenient ways for you to buy CRISPR Therapeutics, and we try our best to fully inform our users about each cryptocurrency we offer on the exchange. However, we are not responsible for the results that may arise from your CRISPR Therapeutics purchase. This page and any information included are not an endorsement of any particular cryptocurrency. Any price and other information on this page is collected from the public internet and can not be consider as an offer from Bitget.
    share